Clinical Trial Update: Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease [Phase 3]

View source ↗

Summary

Pfizer-sponsored Phase 3 trial evaluating Sumanirole for early Parkinson disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Sumanirole (sumanirole)

Snippet

Sponsor: Pfizer | Conditions: Parkinson Disease | Phase 3 | Status: COMPLETED